Filing Flows › Emergent BioSolutions (EBS) › Net income
Emergent BioSolutions (EBS) net income by quarter
Emergent BioSolutions' net income was $6.8M in Q1 2026 (first quarter 2026), -87% from Q3 2025. Over the last 3 quarters it ranged from $6.8M (Q1 2026) to $68.0M (Q1 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | $6.8M | -87% | -90% |
| Q3 2025 | $51.2M | -25% | — |
| Q1 2025 | $68.0M | — | — |
Q1 2026 at a glance
Emergent BioSolutions, Q1 2026: revenue $156M (-30% year over year), operating margin 6.7%, net earnings $6.8M, operating cash flow −$33.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Emergent BioSolutions' net income?
Emergent BioSolutions' net income was $6.8M in Q1 2026 (first quarter 2026), -87% from Q3 2025.
How has Emergent BioSolutions' net income changed?
Over the last 3 quarters it ranged from $6.8M (Q1 2026) to $68.0M (Q1 2025).